423 related articles for article (PubMed ID: 19482850)
1. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.
Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N
Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
Meurin P; Tabet JY; Weber H; Renaud N; Ben Driss A
Circulation; 2006 Jan; 113(4):564-9. PubMed ID: 16449734
[TBL] [Abstract][Full Text] [Related]
3. [The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].
Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
Pol Merkur Lekarski; 2005 May; 18(107):503-10. PubMed ID: 16161943
[TBL] [Abstract][Full Text] [Related]
4. Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement.
Perissinotti AJ; Dotson B; Baciewicz FA; Tennenberg SD
Ann Pharmacother; 2012 Mar; 46(3):e9. PubMed ID: 22353236
[TBL] [Abstract][Full Text] [Related]
5. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
[TBL] [Abstract][Full Text] [Related]
6. Early anticoagulation after mechanical valve implantation, and related complications.
Puri D; Kumar A; Basu R; Chaudhary A; Sarwal V; Sahoo M; Mahant TS
J Heart Valve Dis; 2008 Jul; 17(4):418-24; discussion 425. PubMed ID: 18751472
[TBL] [Abstract][Full Text] [Related]
7. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
[TBL] [Abstract][Full Text] [Related]
8. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
[TBL] [Abstract][Full Text] [Related]
9. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey.
Kulik A; Rubens FD; Baird D; Wells PS; Kearon C; Mesana TG; Lam BK
J Heart Valve Dis; 2006 Jul; 15(4):581-7. PubMed ID: 16901058
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
[TBL] [Abstract][Full Text] [Related]
11. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?
Jamieson WR; Moffatt-Bruce SD; Skarsgard P; Hadi MA; Ye J; Fradet GJ; Abel JG; Janusz MT; Cheung A; Germann E
Ann Thorac Surg; 2007 Feb; 83(2):549-56; discussion 556-7. PubMed ID: 17257986
[TBL] [Abstract][Full Text] [Related]
12. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
[TBL] [Abstract][Full Text] [Related]
13. Exclusive low-molecular-weight heparin as bridging anticoagulant after mechanical valve replacement.
Kindo M; Gerelli S; Hoang Minh T; Zhang M; Meyer N; Announe T; Bentz J; Mansour Z; Mommerot A; Petit-Eisenmann H; Kremer H; Collange O; Pottecher J; Cristinar M; Thiranos JC; Billaud P; Mazzucotelli JP
Ann Thorac Surg; 2014 Mar; 97(3):789-95. PubMed ID: 24206968
[TBL] [Abstract][Full Text] [Related]
14. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
[TBL] [Abstract][Full Text] [Related]
15. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
[TBL] [Abstract][Full Text] [Related]
16. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
[TBL] [Abstract][Full Text] [Related]
17. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
[TBL] [Abstract][Full Text] [Related]
18. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
[TBL] [Abstract][Full Text] [Related]
19. Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation.
Cheng M; Hua W; Chen K; Pu J; Ren X; Zhao X; Liu Z; Wang F; Chen X; Zhang S
Europace; 2009 Sep; 11(9):1183-7. PubMed ID: 19666639
[TBL] [Abstract][Full Text] [Related]
20. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
